Literature DB >> 9315139

A comparative study of embedded nerve tissue in six NF2-associated schwannomas and 17 nonassociated NF2 schwannomas.

Y Hamada1, T Iwaki, M Fukui, J Tateishi.   

Abstract

BACKGROUND: Neurofibromatosis-2 (NF2) is an autosomal dominant disorder in which patients typically show bilateral acoustic tumors, and they are usually diagnosed histopathologically as schwannomas. The nerve of origin of a schwannoma is often demonstrated on the periphery along the capsule but not penetrating the substance of the tumor. However, there is a possibility that NF2 schwannomas and solitary schwannomas differ from participation in nerve components.
METHODS: In this study, the authors noted the relationship between the tumor and the original nerves. To detect whether there were embedded nerves in the tumor, immunohistologic staining using neurofilament and myelin basic protein antibodies was performed on 6 NF2 schwannomas and 17 non-NF2 schwannomas.
RESULTS: Four of five NF2 schwannomas had embedded nerves and one of four, which was considered to be the early stage of the tumor occurrence, remarkably embedded original nerves. On the other hand, embedded nerves were not seen in non-NF2 schwannomas.
CONCLUSIONS: The authors concluded that the NF2 schwannomas tend have original nerves embedded in the tumor substance, which may be based on the difference of the motility of tumor cells, and the authors believe that it is difficult to remove NF2 schwannomas while preserving the original nerve.

Entities:  

Mesh:

Year:  1997        PMID: 9315139     DOI: 10.1016/s0090-3019(96)00487-9

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  6 in total

1.  Superficial neurofibromas in the setting of schwannomatosis: nosologic implications.

Authors:  Fausto J Rodriguez; Bernd W Scheithauer; David George; Rajiv Midha; Mia MacCollin; Anat O Stemmer-Rachamimov
Journal:  Acta Neuropathol       Date:  2010-12-30       Impact factor: 17.088

2.  Aberrant axon neurofilaments in schwannomas associated with phacomatoses.

Authors:  Janine Wechsler; Laurent Lantieri; Jacques Zeller; Marie-Catherine Voisin; Nadine Martin-Garcia; Pierre Wolkenstein
Journal:  Virchows Arch       Date:  2003-09-24       Impact factor: 4.064

Review 3.  Neurofibromatosis: A Review of NF1, NF2, and Schwannomatosis.

Authors:  Jesse Lee Kresak; Meggen Walsh
Journal:  J Pediatr Genet       Date:  2016-03-09

Review 4.  Suggested response criteria for phase II antitumor drug studies for neurofibromatosis type 2 related vestibular schwannoma.

Authors:  Scott R Plotkin; Chris Halpin; Jaishri O Blakeley; William H Slattery; D Bradley Welling; Susan M Chang; Jay S Loeffler; Gordon J Harris; A Gregory Sorensen; Michael J McKenna; Fred G Barker
Journal:  J Neurooncol       Date:  2009-05-09       Impact factor: 4.130

5.  Factors predicting growth of vestibular schwannoma in neurofibromatosis type 2.

Authors:  Eiji Ito; Kiyoshi Saito; Hiroshi Yatsuya; Tetsuya Nagatani; Goro Otsuka
Journal:  Neurosurg Rev       Date:  2009-08-12       Impact factor: 3.042

Review 6.  An update on the CNS manifestations of neurofibromatosis type 2.

Authors:  Shannon Coy; Rumana Rashid; Anat Stemmer-Rachamimov; Sandro Santagata
Journal:  Acta Neuropathol       Date:  2019-06-04       Impact factor: 17.088

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.